
June 15 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA PROVIDES SAFETY UPDATE FOR ELEVIDYS AND INITIATES STEPS TO STRENGTHEN SAFETY IN NON-AMBULATORY INDIVIDUALS WITH DUCHENNE
SAREPTA THERAPEUTICS INC - SECOND CASE OF ACUTE LIVER FAILURE RESULTING IN DEATH REPORTED
SAREPTA THERAPEUTICS INC - SHIPMENTS OF ELEVIDYS FOR NON-AMBULATORY PATIENTS SUSPENDED
SAREPTA THERAPEUTICS INC - ENVISION STUDY PAUSED FOR PROTOCOL AMENDMENT
SAREPTA THERAPEUTICS INC - FDA CONCURS WITH PAUSE IN ENVISION STUDY DOSING
SAREPTA THERAPEUTICS INC - EVENT REPORTED TO FDA AND GLOBAL HEALTH AUTHORITIES